Oct 18, 2024
The dynamics of the schizophrenia treatment market is expected to change in future. Key companies are evaluating lead assets to improve treatment space.
Read More...
Oct 10, 2024
The GBM market size in the 7MM following the launch of a few of many emerging therapies is likely to reach 1,083 million by 2023.
Read More...
Sep 30, 2024
Pompe Disease Therapeutics market is evolving immensely with the active participation of key companies such as Sanofi, Actus, Amicus
Read More...
Aug 23, 2024
Several pharmaceutical companies are developing a gene therapy that will positively impact the Duchenne Muscular Dystrophy Treatment Market
Read More...
Aug 20, 2024
As per DelveInsight, the DMD market is expected to generate over $8,000 million in revenue in the 7MM
Read More...
Jul 25, 2024
BMS has established a comprehensive treatment strategy, with CELMODs replacing REVLIMID in earlier lines of multiple myeloma treatment.
Read More...
May 29, 2024
Artificial blood vessels represent a critical frontier in medical research, offering significant promise for treating cardiovascular diseases and enhancing surgical outcomes. Future directions in this field are focused on developing materials that can closely mimic the natural properties of human blood vessels.
Read More...
May 27, 2024
Potential therapies are being investigated for retinal vein occlusion treatment. Even though it is too soon to comment on the promising candidate to enter the market, it is safe to assume that the future of the retinal vein occlusion treatment market is promising.
Read More...
May 24, 2024
It is estimated that the cervical cancer treatment space will experience significant changes during the forecast period of 2024–2034. The future is brighter for patients with cervical cancer. Targeted agents and biomarker-driven therapies hold promise for improved outcomes both as single agents and combinations.
Read More...
May 22, 2024
The future directions for the surgical camera market are promising, with a focus on enhancing image quality, reducing costs, and improving ease of use. Innovations such as 3D imaging, robotic integration, and artificial intelligence are expected to revolutionize the field, making surgeries more precise and less invasive.
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper